Delivery Order SPE2DB22D1017-SPE2DB25FYSGM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $25,277.89 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packages) on September 9, 2025, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packaging) with a ceiling value of $12,688.65. This firm fixed-price delivery order, which is expected to be completed by September 18, 2025, was competitively awarded without any set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $11,453.04 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count units). This is a firm fixed-price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 2, 2025. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to meet federal procurement requirements in open competition. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for NURTEC ODT 75 mg tablets in a quantity of 8 units, with a ceiling value of $10,237.72. This firm fixed price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by September 3, 2025. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $129,179.08 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a continuation of AmerisourceBergen's substantial pharmaceutical supply relationship with the federal government. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $35,332.72 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitive award, executed under firm fixed pricing with no set-aside designation, leverages AmerisourceBergen's established pharmaceutical distribution capabilities to support federal medical procurement needs. The delivery will be performed at the contractor's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of NURTEC ODT 75 MG tablets (8-count packages) with a ceiling value of $18,152.90. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through the open market. The order is scheduled for completion by August 15, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $46,983.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units). The contract, designated as a non-set-aside competitive award, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order represents a single transaction within AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 29, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count units) with a ceiling value of $1,132.01 under a firm fixed-price contract. This non-set-aside delivery order is scheduled for completion by May 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's critical role as a pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a contract value of $4,344.84. This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and does not utilize any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSGMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of NURTEC ODT 75 MG tablets in quantities of eight units, with a ceiling value of $26,185.35. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the company's capability to compete in open federal procurement processes. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The broader IDC serves as a global pharmaceutical support vehicle enabling the company to deliver specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.2k | 9/29/25 |